NLCAX
Price
$56.92
Change
-$0.08 (-0.14%)
Updated
Dec 3 closing price
Net Assets
849.92M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

NLCAX vs VIGRX

Header iconNLCAX vs VIGRX Comparison
Open Charts NLCAX vs VIGRXBanner chart's image
Voya Large-Cap Growth A
Price$56.92
Change-$0.08 (-0.14%)
VolumeN/A
Net Assets849.92M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
NLCAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
NLCAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLCAX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. NLCAX (850M). VIGRX pays higher dividends than NLCAX: VIGRX (0.30) vs NLCAX (0.00). NLCAX was incepted earlier than VIGRX: NLCAX (28 years) vs VIGRX (33 years). NLCAX (0.89) is less costly to investors than VIGRX (0.17). NLCAX is a more actively managed with annual turnover of: 56.00 vs. VIGRX (11.00). NLCAX has a lower initial minimum investment than VIGRX: NLCAX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. NLCAX (9.69). VIGRX return over 5 years is better than : 99.11 vs. NLCAX (4.92).
NLCAXVIGRXNLCAX / VIGRX
Total Expense Ratio0.890.17524%
Annual Report Gross Expense Ratio0.890.17524%
Fund Existence28 years33 years-
Gain YTD15.85619.76480%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets850M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year9.6918.4952%
Returns for 3 years51.83110.8247%
Returns for 5 years4.9299.115%
Returns for 10 years80.74349.1323%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT